Follow
Evans DG*, Evans G*
Evans DG*, Evans G*
University of Manchester
Verified email at mft.nhs.uk
Title
Cited by
Cited by
Year
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
L Jostins, S Ripke, RK Weersma, RH Duerr, DP McGovern, KY Hui, ...
Nature 491 (7422), 119-124, 2012
50792012
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies
A Antoniou, PDP Pharoah, S Narod, HA Risch, JE Eyfjord, JL Hopper, ...
American journal of human genetics 72 (5), 1117, 2003
46982003
Genome-wide association study identifies novel breast cancer susceptibility loci
DF Easton, KA Pooley, AM Dunning, PDP Pharoah, D Thompson, ...
Nature 447 (7148), 1087-1093, 2007
27952007
Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers
KB Kuchenbaecker, JL Hopper, DR Barnes, KA Phillips, TM Mooij, ...
Jama 317 (23), 2402-2416, 2017
26472017
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group
Lancet (London, England) 397 (10285), 1637, 2021
1971*2021
Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations
TR Rebbeck, HT Lynch, SL Neuhausen, SA Narod, L Van't Veer, ...
New England Journal of Medicine 346 (21), 1616-1622, 2002
18562002
Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality
SM Domchek, TM Friebel, CF Singer, DG Evans, HT Lynch, C Isaacs, ...
Jama 304 (9), 967-975, 2010
16612010
Bilateral Prophylactic Mastectomy Reduces Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group
TR Rebbeck, T Friebel, HT Lynch, SL Neuhausen, L Van’t Veer, ...
Journal of clinical oncology 22 (6), 1055-1062, 2004
15102004
Low-penetrance susceptibility to breast cancer due to CHEK2* 1100delC in noncarriers of BRCA1 or BRCA2 mutations
H Meijers-Heijboer, A van den Ouweland, J Klijn, M Wasielewski, ...
Nature genetics 31 (1), 55-59, 2002
14032002
Malignant peripheral nerve sheath tumours in neurofibromatosis 1
DGR Evans, ME Baser, J McGaughran, S Sharif, E Howard, A Moran
Journal of medical genetics 39 (5), 311-314, 2002
13822002
Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002)
SR Cairns, JH Scholefield, RJ Steele, MG Dunlop, HJW Thomas, ...
Gut 59 (5), 666-689, 2010
13192010
Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS).
MO Leach, CR Boggis, AK Dixon, DF Easton, RA Eeles, DG Evans, ...
Lancet 365 (9473), 1769, 2005
13032005
Large-scale genotyping identifies 41 new loci associated with breast cancer risk
K Michailidou, P Hall, A Gonzalez-Neira, M Ghoussaini, J Dennis, ...
Nature genetics 45 (4), 353-361, 2013
12562013
PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene
N Rahman, S Seal, D Thompson, P Kelly, A Renwick, A Elliott, S Reid, ...
Nature genetics 39 (2), 165-167, 2007
11692007
Guidelines for the diagnosis and management of individuals with neurofibromatosis 1
RE Ferner, SM Huson, N Thomas, C Moss, H Willshaw, DG Evans, ...
Journal of medical genetics 44 (2), 81-88, 2007
11662007
Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial
J Burn, AM Gerdes, F Macrae, JP Mecklin, G Moeslein, S Olschwang, ...
The Lancet 378 (9809), 2081-2087, 2011
11292011
The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in …
SR Lakhani, MJ Van De Vijver, J Jacquemier, TJ Anderson, PP Osin, ...
Journal of clinical oncology 20 (9), 2310-2318, 2002
11112002
Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE
N Mavaddat, S Peock, D Frost, S Ellis, R Platte, E Fineberg, DG Evans, ...
JNCI: Journal of the National Cancer Institute 105 (11), 812-822, 2013
10742013
Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas
C Palles, JB Cazier, KM Howarth, E Domingo, AM Jones, P Broderick, ...
Nature Genetics, 2012
10672012
The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women
MN Harvie, M Pegington, MP Mattson, J Frystyk, B Dillon, G Evans, ...
International journal of obesity 35 (5), 714-727, 2011
10152011
The system can't perform the operation now. Try again later.
Articles 1–20